Clinical Trial Update: Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Rituximab to Tositumomab with I-131 Tositumomab in relapsed follicular lymphoma has completed and posted results in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Rituximab (rituximab)
• Tositumomab (tositumomab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Non-Hodgkin | Phase 3 | Status: COMPLETED | Results posted: 2010-08-02